Mammoth Biosciences
Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics.
All edits
Edits on 7 Jun, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Country
Edits made to:
Infobox (+1 properties)
Infobox
Wikidata ID
Edits on 22 May, 2021
Edits made to:
Timeline (+1/-1 events) (+177/-183 characters)
Timeline
March 8, 2021
Mammoth Biosciences today announced that it has been named by Fierce Medtech as one of 2020's Fierce 15, designating it as one of the most promising private companies in the industry.
March 8, 2021
Mammoth Biosciences announces that it has been named by Fierce Medtech as one of 2020's Fierce 15, designating it as one of the most promising private companies in the industry.
Edits made to:
Timeline (+1 events) (+183 characters)
Timeline
March 8, 2021
Mammoth Biosciences today announced that it has been named by Fierce Medtech as one of 2020's Fierce 15, designating it as one of the most promising private companies in the industry.
Edits on 11 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding type
Edits on 3 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
DUNS Number
081179621
Edits on 27 Apr, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Location
Edits made to:
Infobox (+1/-1 properties)
Infobox
Full address
279 East Grand Avenue, Suite 400, South San Francisco, CA, 94080, United States
Full address
1000 Marina Blvd. Suite 600 Brisbane CA 94005
Edits on 15 Apr, 2021
Edits made to:
Infobox (+2/-2 properties)
Infobox
Latest funding round date
January 30, 2020
Total funding amount (USD)
68,000,000
Latest funding round date
July 2020
Total funding amount (USD)
68,120,000
Edits made to:
Infobox (+2 properties)
Infobox
Investors
Edits made to:
Infobox (+1 properties)
Infobox
Investors
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Edits on 29 Mar, 2021
Edits made to:
Infobox (+4 properties)
Infobox
Investors
Edits on 17 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Founder
Edits made to:
Infobox (+1 properties)
Infobox
Founder
Edits made to:
Infobox (+1 properties)
Infobox
Founder
Edits made to:
Infobox (+1 properties)
Infobox
CTO
Edits on 10 Feb, 2021
Edits made to:
Timeline (+1 events) (+179 characters)
Timeline
January 28, 2021
Mammoth Biosciences, Inc. announced a co-marketing agreement with Agilent Technologies to support the anticipated launch of a complete CRISPR-based SARS-CoV-2 diagnostic solution.
Edits on 18 Nov, 2020
Edits made to:
Infobox (+2 properties)
Infobox
Accelerator
Accelerator Batch
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.